NCT00720174 2016-05-17Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue SarcomaNational Cancer Institute (NCI)Phase 1 Completed30 enrolled